/EAR

EAR Stock - Eargo, Inc.

Q: What is the analyst price target for EAR?

Analyst price target information is not currently available for EAR.

Q: What is EAR's market cap?

Market capitalization information is not currently available for EAR.

Healthcare|Medical - Devices|NASDAQ

$2.57-4.10%

$0.11 (-4.10%) • Feb 15

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.83

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EAR

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.48

52W High$8.48

52W Low$1.47

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$37.25M	$32.12M	$69.15M	$32.79M	$23.16M
Gross Profit	$14.26M	$4.17M	$47.28M	$17.00M	$11.74M
Gross Margin	38.3%	13.0%	68.4%	51.8%	50.7%
Operating Income	$-111,759,000	$-156,707,000	$-34,871,000	$-44,036,000	$-31,571,000
Net Income	$-157,487,000	$-157,754,000	$-30,015,000	$-44,486,000	$-33,793,000
Net Margin	-422.8%	-491.1%	-43.4%	-135.7%	-145.9%
EPS	$-39.68	$-81.11	$-38.92	$-3469.23	$-2993.71

Company Overview

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Visit Website

Earnings History & Surprises

EAR

Beat Rate

33%

Last 12 quarters

Avg Surprise

-16.2%

EPS vs Estimate

Beats / Misses

4/8

Last 12 quarters

Latest EPS

$-0.71

Q4 2023

EPS Surprise History

Q2 22

-343.9%

$-37.60vs$-8.47

Q2 22

-358.8%

$-15.60vs$-3.40

Q3 22

-239.1%

$-15.60vs$-4.60

Q4 22

-137.3%

$-24.20vs$-10.20

Q1 23

-318.0%

$-4.18vs$-1.00

Q2 23

+52.6%

$-0.90vs$-1.90

Q3 23

-11.3%

$-1.08vs$-0.97

Q4 23

+26.6%

$-0.71vs$-0.97

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Nov 7, 2023	$-0.97	$-0.71	+26.6%	✓ BEAT
Q3 2023	Aug 10, 2023	$-0.97	$-1.08	-11.3%	✗ MISS
Q2 2023	May 11, 2023	$-1.90	$-0.90	+52.6%	✓ BEAT
Q1 2023	Mar 23, 2023	$-1.00	$-4.18	-318.0%	✗ MISS
Q4 2022	Nov 3, 2022	$-10.20	$-24.20	-137.3%	✗ MISS
Q3 2022	Aug 8, 2022	$-4.60	$-15.60	-239.1%	✗ MISS
Q2 2022	May 24, 2022	$-3.40	$-15.60	-358.8%	✗ MISS
Q2 2022	May 13, 2022	$-8.47	$-37.60	-343.9%	✗ MISS
Q2 2022	May 13, 2022	—	$-40.47	—	—
Q3 2021	Aug 12, 2021	$-5.00	$-7.20	-44.0%	✗ MISS
Q2 2021	May 12, 2021	$-5.40	$-4.40	+18.5%	✓ BEAT
Q1 2021	Feb 25, 2021	$-4.20	$-6.00	-42.9%	✗ MISS
Q4 2020	Nov 19, 2020	$-7.40	$81.60	+1202.7%	✓ BEAT
Q2 2020	Jun 30, 2020	—	$-473.19	—	—
Q1 2020	Mar 31, 2020	—	$-875.25	—	—
Q4 2019	Dec 31, 2019	—	$-1008.31	—	—
Q3 2019	Sep 30, 2019	—	$-925.26	—	—